当前位置: X-MOL首页全球导师 国内导师 › 何应

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

何应, 魏树礼. Study on preparative conditions for polylactide microspheres containing tetanus toxoid. 北京医科大学学报, 2000, 32(3): 239-243 何应, 柳翠敬. Oral drug delivery systems for colon targeting. 中国药房, 2000, 11(3): 136-137 何应, 魏树礼. Study on the in vitro release of tetanus toxoid from polylactide microspheres and influences on the drug release by additives. 北京大学学报(医学版), 2001, 33(3): 228-232 何应, 柳林, 魏树礼. Protein stability of tetanus toxoid encapsulated in polylactide microspheres. 中国药学杂志, 2001, 36(6): 391-394 何应, 魏树礼. The degradation of polylactide microspheres in vitro. 中国药学(英文版), 2001, 10(1): 20-23 何应, 魏树礼. Study on the degradation of polylactide microspheres. 北京大学学报(医学版), 2001, 33(4): 358-361 何应, 陈志华, 魏树礼. Long term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery. 药学学报, 2001, 36(9): 695-698 何应, 陈志华, 魏树礼. Study on immunogenicity of single-dose delivery for tetanus toxoid encapsulated in microspheres. 北京大学学报(医学版), 2002, 34(1): 61-63 黎洪珊, 何应, 魏树礼. Recent studies on vaccine delivery systems. 中国药学杂志, 1999, 34(5): 291-296 HE Ying, DAS Bikul, BARUCHEL Sylvain, WIEBE Leonard, REILLY Raymond. 123I-MIBG is selectively radiotoxic to human neuroblastoma cells expressing norepinephrine transporters. Nuclear Medicine and Biology, submitted

推荐链接
down
wechat
bug